This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skinner-Adams, T.
Right arrow Articles by Davis, T. M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skinner-Adams, T.
Right arrow Articles by Davis, T. M. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 1999, p. 1304-1306, Vol. 43, No. 5
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Synergistic In Vitro Antimalarial Activity of Omeprazole and Quinine

T. Skinner-Adams* and T. M. E. Davis

Department of Medicine, University of Western Australia, Fremantle Hospital, Fremantle, Western Australia 6160, Australia

Received 18 November 1998/Returned for modification 4 January 1999/Accepted 8 March 1999

Previous studies have shown that the proton pump inhibitor omeprazole has antimalarial activity in vitro. The interactions of omeprazole with commonly used antimalarial drugs were assessed in vitro. Omeprazole and quinine combinations were synergistic; however, chloroquine and omeprazole combinations were antagonistic. Artemisinin drugs had additive antimalarial activities with omeprazole.


* Corresponding author. Mailing address: University of Western Australia, Department of Medicine, Fremantle Hospital, P.O. Box 480, Fremantle, Western Australia 6160, Australia. Phone: 9431 2523. Fax: 9431 2977. E-mail: tskinner{at}cyllene.uwa.edu.au.


Antimicrobial Agents and Chemotherapy, May 1999, p. 1304-1306, Vol. 43, No. 5
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Namazi, M. (2009). The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine. Lupus 18: 104-105  
  • Stack, C. M., Lowther, J., Cunningham, E., Donnelly, S., Gardiner, D. L., Trenholme, K. R., Skinner-Adams, T. S., Teuscher, F., Grembecka, J., Mucha, A., Kafarski, P., Lua, L., Bell, A., Dalton, J. P. (2007). Characterization of the Plasmodium falciparum M17 Leucyl Aminopeptidase: A PROTEASE INVOLVED IN AMINO ACID REGULATION WITH POTENTIAL FOR ANTIMALARIAL DRUG DEVELOPMENT. J. Biol. Chem. 282: 2069-2080 [Abstract] [Full Text]  
  • Davis, T. M. E., Hamzah, J., Ilett, K. F., Karunajeewa, H. A., Reeder, J. C., Batty, K. T., Hackett, S., Barrett, P. H. R. (2006). In Vitro Interactions between Piperaquine, Dihydroartemisinin, and Other Conventional and Novel Antimalarial Drugs.. Antimicrob. Agents Chemother. 50: 2883-2885 [Abstract] [Full Text]  
  • Gardiner, D. L., Trenholme, K. R., Skinner-Adams, T. S., Stack, C. M., Dalton, J. P. (2006). Overexpression of Leucyl Aminopeptidase in Plasmodium falciparum Parasites: TARGET FOR THE ANTIMALARIAL ACTIVITY OF BESTATIN. J. Biol. Chem. 281: 1741-1745 [Abstract] [Full Text]  
  • Riel, M. A., Kyle, D. E., Bhattacharjee, A. K., Milhous, W. K. (2002). Efficacy of Proton Pump Inhibitor Drugs against Plasmodium falciparum In Vitro and Their Probable Pharmacophores. Antimicrob. Agents Chemother. 46: 2627-2632 [Abstract] [Full Text]  
  • Akompong, T., Eksi, S., Williamson, K., Haldar, K. (2000). Gametocytocidal Activity and Synergistic Interactions of Riboflavin with Standard Antimalarial Drugs against Growth of Plasmodium falciparum In Vitro. Antimicrob. Agents Chemother. 44: 3107-3111 [Abstract] [Full Text]